Objective: To investigate the cross-sectional relation between metabolic markers of vitamin B 12 status and cognitive performance, and possible effect modification by the presence of depression and apolipoprotein E (ApoE) ?4. Methods: This is a population-based study of 1935 participants, aged 71 to 74 years, from Norway. Participants were administered a cognitive test battery, and vitamin B 12 status was assessed by measurements of plasma vitamin B 12 , holotranscobalamin (holoTC), methylmalonic acid (MMA), and total homocysteine. Results: The geometric mean (95% confidence interval) for vitamin B 12 was 348 pM (341Y354), whereas 5.9% of participants had vitamin B 12 levels lower than 200 pM. In linear regression analyses, holoTC ( p = .039) and the holoTC/vitamin B 12 ratio ( p = .013) were positively related, whereas MMA ( p = .010) was inversely related, to global cognition, after adjustment for sex, education, ApoE status, plasma creatinine, and history of diabetes, cardiovascular disease, hypertension, and depression. Among those positive for ApoE ?4, but not among those without the ?4 allele, plasma vitamin B 12 was positively associated with global cognition ( p = .015), whereas MMA was inversely related to global cognition ( p = .036) and executive function ( p = .014). In participants with depression, MMA was inversely associated with global cognition ( p G .001) and episodic memory ( p = .001). Conclusions: Among the well-nourished elderly, low vitamin B 12 status is associated with cognitive deficit, particularly in those with the ApoE ?4 allele or with depression. Key words: plasma vitamin B 12 status, methylmalonic acid, holotranscobalamin, depression, apolipoprotein E ?4, cognitive performance. 
INTRODUCTION
P rogression of cognitive impairment and development of dementia are complex processes involving several genes and synergistic interactions with and between environmental factors (1) . Vitamin B 12 deficiency has been suggested as an important modifiable factor, and there are reports that its association with cognitive decline may depend on the presence of genetic polymorphisms, such as apolipoprotein E (ApoE) ?4 (2,3), and coexisting depression (4) .
Subnormal plasma levels of vitamin B 12 are prevalent among the elderly (5, 6) and may be associated with megaloblastic anemia, neurologic disorders (such as neuropathy, myelopathy, dementia, depression, and brain atrophy), and cerebrovascular disease (7Y11). Several studies have reported on the benefits of high levels of vitamin B 12 on cognition or on associations between low vitamin B 12 levels and cognitive deficit among community-dwelling elderly people and patients with cognitive impairment, whereas others have yielded null results (12, 13) . The results of these studies are inconclusive, possibly because of differences in the diagnosis of vitamin B 12 deficiency and in the assessment of cognitive function, but perhaps also because other synergistic factors have not been identified.
The standard clinical screening test for the diagnosis of vitamin B 12 deficiencyVmeasurement of plasma or serum vitamin B 12 Vhas low diagnostic accuracy (14) , whereas plasma levels of total homocysteine (tHcy) and methylmalonic acid (MMA) are considered to be more sensitive markers of vitamin B 12 status (14, 15) . Holotranscobalamin (holoTC)Vthe portion of vitamin B 12 bound to the transport protein transcobalamin (TC)Vand the related TC saturation (the fraction of total TC present as holoTC) represent the biologically active fraction of total vitamin B 12 and have been proposed as potentially useful indicators of vitamin B 12 status (16, 17) . A recent study (4) suggested that the percentage of total vitamin B 12 bound to TC (holoTC/B 12 ratio) may provide important information about the availability of vitamin B 12 for delivery to the tissues and may possibly provide a sensitive measure of vitamin B 12 status. These markers, used in conjunction with total vitamin B 12 , may allow for better discrimination of vitamin B 12 status than total vitamin B 12 alone (18, 19) .
ApoE is involved in the regulation and transport of lipids and is believed to have regulatory properties over the deposition and formation of amyloid plaques and neurofibrillary tangles, both hallmarks of Alzheimer's disease (20) . The presence of the ApoE ?4 allele is the major genetic risk factor associated with an increased risk of dementia (21Y25). Furthermore, individuals with the ApoE ?4 genotype are more vulnerable to the influence of other nongenetic risks for dementia (26) .
Depression may accelerate cognitive decline and is believed to have an additive effect on adverse outcomes for physical health, functional status, and mortality (27) . Low vitamin B 12 status has been found in studies of patients with depression (9,28Y32), and an association between depression and low vitamin B 12 has been found in the general population (33Y35). Although limited, there is evidence that the associations between plasma vitamin B 12 or markers of vitamin B 12 status and cognitive function test scores (4,36Y38) are stronger in patients with depression than in patients without depression.
The aim of this cross-sectional study on approximately 2000 community-dwelling elderly people was to assess the associations of several markers of plasma vitamin B 12 status with specific cognitive domains. In particular, we wished to see if the presence of two factors already shown to influence cognition in this population, ApoE ?4 allele (39) and depressive symptoms (40) , might modulate the association with vitamin B 12 .
METHODS

Study Participants
The Hordaland Health Study was conducted from 1997 to 1999 as collaboration between the National Health Screening Service, the University of Bergen, and local health services (41) . All attending participants from the city of Bergen who were born in the period 1925 to 1927 and attended the Hordaland Homocysteine Study in 1992 to 1993 were invited to participate in cognitive testing (41) . The present study population includes the group of 1967 participants who underwent cognitive examination. Those who reported having injections of vitamin B 12 (n = 32) were excluded, leaving 1935 participants for analysis. The study protocol was approved by the Regional Committee for Medical Research Ethics and the Norwegian Data Inspectorate. All participants gave their written informed consent to participate in the study.
Health Examination and Analytic Procedures
Participants underwent a brief health examination and provided a nonfasting blood sample. Information on diet, life-style, and medical history was collected via self-administered questionnaires (41) . The health examination included measurements of height, weight, and blood pressure. Nonfasting plasma samples were collected into tubes containing EDTA and stored at j80-C for biochemical analyses. Plasma tHcy was determined by automated highperformance liquid chromatography with fluorescence detection (42) . The concentrations of plasma folate and vitamin B 12 were measured by Lactobacillus casei (43) and Lactobacillus leichmannii microbiological assays (44) , respectively. Plasma MMA was analyzed by using a modified gas liquid chromatographyYmass spectrometry method based on ethylchloroformate derivatization (45) . Plasma holoTC was measured by a microbiological assay developed for cobalamin estimation (17) that was adapted to a microtiter plate format and carried out by a robotic workstation (Perkin-Elmer MultiProbe11). Total TC was measured as holoTC after the binding sites had been saturated with cyanocobalamin (17) . Plasma creatinine was measured by a modified liquid chromatographyYmass spectrometry procedure (46) . ApoE genotypes were determined using a one-stage polymerase chain reaction method (47) .
Assessment of Cognitive and Mental Status
Cognitive testing was performed at the study location by specially trained nurses. The six cognitive tests included the following: a modified version of the Mini-Mental State Examination (m-MMSE; global cognition), the Kendrick Object Learning Test (KOLT; episodic memory), a modified version of the Digit Symbol Test (m-DST; perceptual speed), the abridged version (S-task) of the Controlled Oral Word Association Test (COWAT; access to semantic memory), part A of the Trail Making Test (TMT-A; executive function), and a modified version of Block Design (m-BD; visuospatial skills). All cognitive tests have been previously described in detail (48) . In all tests, except for TMT-A, a lower score indicates poorer performance. Levels of anxiety and depression symptoms were assessed by the seven-item Hospital Anxiety and Depression Scale, anxiety subscale, and the seven-item Hospital Anxiety and Depression Scale, depression subscale (HADS-D), respectively (49) . In this study, only HADS-D score was used as it is more relevant to cognitive function. All participants completed at least one cognitive test; 48 individuals were not assessed for depression. The observations for which the scores of the various cognitive tests were missing were less than 1% of the sample; in all participants, when an observation did not include data on the cognitive score in question, that observation was not included in the relevant analysis.
Statistical Analyses
All calculations were performed using SPSS version 15.0 (SPSS, Inc., Chicago, IL). Results are expressed as means and 95% confidence intervals. The distributions of plasma markers of vitamin B 12 status were markedly skewed; log-transformed data were used in all analyses and backtransformed for the presentation of geometric means and 95% confidence intervals. For comparison between groups, W 2 test was used. Cutoff points for poor cognitive test scores were set at about the 10th percentile of the cognitive test score, except for TMT-A, for which the 90th percentile was used (48) . As in a previous report on this population, a HADS-D score higher than 7 is suggestive of depression (40) . Pearson correlation coefficients were used to assess simple correlations between plasma variables and cognitive test scores.
Multiple linear regression analyses were used to describe the associations between plasma vitamin B 12 markers (independent variables) and cognitive tests (dependent variables). Adjustment variables included sex (male or female), years of education (elementary school or G10 years, technical or high school, or college or Q13 years), ApoE status (ApoE ?4Ypositive or ApoE ?4Ynegative), diabetes (yes or no), cardiovascular disease (yes or no), depression (continuous), hypertension (yes or no), and plasma creatinine (continuous); for analyses that included tHcy, plasma folate (continuous) was also added in the adjustments. The interaction between vitamin B 12 markers and ApoE ?4 status or depression score was analyzed and presented separately by adding relevant interaction terms to the above multiple linear regression models. This analysis was performed separately because the multicollinearity introduced by the addition of the interaction terms would make the resulting regression coefficients difficult to interpret. As the range of scores of each cognitive test varies, we reported standardized regression coefficients for meaningful cross-comparisons. To further investigate the presence of a significant interaction between vitamin B 12 status and the ApoE ?4 genotype or the presence of depression, we used multiple linear regression models for cognitive test scores stratified by ApoE ?4 status and the presence of depression. This was achieved by splitting the sample into two based on the presence of the ApoE ?4 genotype in the first instance and on the presence of depression in the second instance. The resulting models were also adjusted using the aforementioned variables. Body mass index, smoking status, and physical activity were not related to cognitive test scores or markers of vitamin B 12 status and were excluded from the models because inclusion of these variables in statistical models did not change the results. Log-transformed values were used for both tHcy and folate in linear regression analyses. The participants were homogeneous in age (born 1925Y1927); thus, age was not included in the models.
Gaussian generalized additive regression models implemented in S-PLUS version 8.0 (Insightful Corp., Seattle, WA) were used to generate graphic representations of the dose-response relations between plasma vitamin B 12 status (independent variable) and cognitive test scores (dependent variable), adjusted for covariates included in linear regression models previously described. At A. VOGIATZOGLOU et al.
the approximate mean exposure of the independent variable, the model generates a reference value of zero for the dependent variable. Corresponding p values were obtained from multiple linear regression analyses.
RESULTS
Selected Characteristics of the Study Population
Selected characteristics of the study population are listed in Table 1 . Plasma vitamin B 12 was within the reference range, and only 5.9% had a vitamin B 12 level lower than 200 pM, indicating good vitamin B 12 status in this population. Among the participants, 3.9% had elevated tHcy (920 KM) and 5.1% had elevated MMA (90.37 KM), which are the upper reference limits for tHcy and MMA in this population (15, 50) . Only 1.9% had plasma vitamin B 12 levels lower than 200 pM combined with MMA values higher than 0.37 KM.
The characteristics of the study population according to cognitive deficit in the six cognitive tests are listed in the supplemental table (Supplemental Digital Content 1, http://links.lww.com/PSYMED/A55). Significant differences between participants with normal scores and participants with poor scores were observed in three tests for participants positive for ApoE ?4, in five tests for participants with 10 or less years of education, and in five tests for participants with symptoms of depression.
Univariate Associations
Pearson correlation coefficients between the six cognitive tests and plasma variables are presented in Table 2 . High plasma MMA was associated with poorer scores in tests of global function (m-MMSE), whereas the holoTC/vitamin B 12 ratio and TC saturation showed weak positive associations with the episodic memory test (KOLT). A weak inverse association was observed between plasma vitamin B 12 and semantic memory (COWAT) and perceptual speed (m-DST) test scores. High plasma tHcy was associated with poorer scores in tests of global function (m-MMSE), episodic memory (KOLT), perceptual speed (m-DST), semantic memory (COWAT), and executive function (TMT-A).
Multiple Linear Regression Analyses
Multiple linear regression analysis models for the six cognitive test scores and vitamin B 12 markers are summarized in Table 3 . Table 4 shows the significant associations of the interaction between vitamin B 12 markers and ApoE ?4 status or depression score with cognitive scores in linear regression models. Table 5 presents multiple linear regression models for cognitive test scores stratified by ApoE ?4 status and depression score.
In linear regression analysis, plasma MMA, holoTC, and the holoTC/B 12 ratio were significantly associated with m-MMSE scores after controlling for years of education, sex, ApoE status, history of diabetes and cardiovascular disease, HADS-D score, hypertension, and creatinine, although the associations were relatively weak (Table 3 , Fig. 1 ). As shown in Table 4 , there was a significant interaction between vitamin B 12 and ApoE ?4 on m-MMSE scores. A significant interaction on m-MMSE scores was also observed between depression and vitamin B 12 , holoTC, and MMA (Table 4) . When associations were assessed separately for participants with and without the ApoE ?4 allele, low vitamin B 12 and high MMA were associated with lower m-MMSE scores in those participants with the ApoE ?4 allele, but not in those without the ApoE ?4 allele ( Table 5 , Fig. 2 ). Plasma MMA was inversely associated with m-MMSE and KOLT scores in depressed participants in linear Partial correlations describe the correlation between the dependent variable (rows) and the independent variable in question (columns) after the effects of the other variables from both the dependent variable and the independent variable were removed. Log-transformed data of the independent variables were used in all analyses. a Adjusted for sex, apolipoprotein E ?4 status, education, diabetes, hypertension, cardiovascular disease, plasma creatinine, and Hospital Anxiety and Depression Scale, depression subscale score. b Adjusted for sex, apolipoprotein E ?4 status, education, diabetes, hypertension, cardiovascular disease, plasma creatinine, folate, and Hospital Anxiety and Depression Scale, depression subscale score.
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regression models (Table 5, Fig. 3) . A 10% increase in MMA levels was associated with a 0.3-and 1.6-unit decrease in m-MMSE and KOLT scores, respectively (Table 5) .
High plasma tHcy was associated with deficit in episodic memory, although when stratified by sex, a significant inverse association was found only among men ( p = .001 for men, p = .129 for women). A significant, although weak association with episodic memory scores was observed for the holoTC/B 12 ratio (partial r = 0.07, p = .015) and MMA (partial r = j0.05, p = .038) in linear regression models (Table 3) . There was a significant interaction between depression scores and vitamin B 12 , holoTC, and MMA on KOLT scores (Table 4 ). In depressed participants, there was a stronger inverse association between high plasma MMA and KOLT scores (Table 5 , Fig. 3) , and the associations with low holoTC and TC saturation almost reached significance ( p = .059 for holoTC, p = .056 for TC saturation). For m-DST test scores, a weak inverse association with vitamin B 12 was observed (Table 3) , whereas a significant interaction on m-DST scores was observed between vitamin B 12 and ApoE ?4 (Table 4) . In depressed participants, COWAT scores were positively and more strongly associated with low holoTC and TC saturation (Table 5 , Fig. 3 ). High MMA was associated with poor scores on TMT-A in participants with the ApoE ?4 allele, but not in those without ApoE ?4 (Table 5 , Fig. 2) . High tHcy presented a positive association with TMT-A scores in linear regression models, although when stratified by sex, high plasma tHcy was associated with cognitive deficit on TMT-A only in men ( p = .047 for men, p = .186 for women). The holoTC/B 12 ratio had a significant positive association with m-BD test scores only in those positive for ApoE ?4 (Table 5 ).
DISCUSSION
In this large population-based sample of Norwegian elderly, the most significant finding is that the association of vitamin B 12 status with cognitive test performance is stronger in the presence of the ApoE ?4 allele or in the presence of depression. The relatively weak independent association may be related to the good vitamin B 12 status in this elderly population. As previously reported, the low prevalence of vitamin B 12 deficiency in these community-dwelling elderly was related to high vitamin B 12 intake, which may be related to the high dietary intake of milk and fish among our participants (51) .
The prevalence of vitamin B 12 deficiency in this population was lower than that frequently documented among the elderly (6) . Low vitamin B 12 status may affect up to 43% of the elderly population, as demonstrated by the use of various markers of vitamin B 12 status: low or low-normal vitamin B 12 levels with or without high MMA and tHcy, and low holoTC concentrations (6,7,52Y54). In our study, only 5.9% of the participants were considered deficient in vitamin B 12 (plasma vitamin B 12 G200 pM), whereas 5.1% had high plasma MMA (90.37 KM).
Our findings are in agreement with the results of recent studies suggesting an interaction of vitamin B 12 status and ApoE ?4 genotype on cognitive function (2, 3) . Individuals with the ApoE ?4 allele have a significantly higher risk for cognitive decline (55) and perform significantly worse on measures of episodic memory, executive functioning, and overall global cognitive ability (2,3,39 ). In the current study, plasma vitamin B 12 was positively related to global cognition (m-MMSE), but this association was observed only in those positive for ApoE ?4.
In our study, plasma holoTC and the holoTC/B 12 ratio were positively related to global cognition scores. In a recent study (7) , holoTC was associated with Mini-Mental State Examination scores, whereas in the Oxford Healthy Aging Project, greater cognitive decline over 10 years was associated with lower holoTC concentrations at baseline (56) . Thus, low levels of holoTC frequently occur in Alzheimer's disease (57) . However, another smaller study found no significant correlations between holoTC and cognitive scores (53) . We observed that among depressed participants, COWAT scores were positively associated with holoTC and TC saturation. This is consistent HoloTC with a recent study in which the significant association between the holoTC/B 12 ratio and cognitive function was confined to those participants with depressive symptoms (4).
The results of our study are consistent with the findings of previous cross-sectional studies reporting significant associations between lower performance in global cognition test scores and high levels of MMA (7, 53) . Other studies report associations with high levels of MMA and lower performance in various cognitive domains, such as spatial skills (58), information processing speed, memory, verbal fluency, and nonverbal reasoning (59) . Two recent prospective studies have reported that greater cognitive decline was associated with higher MMA concentrations (54, 56) . However, not all studies have confirmed a correlation between MMA and impaired cognitive function (60, 61) , and there are conflicting data as to whether MMA concentrations are elevated in patients with dementia (57, 62) . It is noteworthy that, in the present study, the inverse association between levels of MMA and global cognition was observed only in those positive for ApoE ?4 and in participants with depression. The interactions between the ApoE ?4 allele, depression, and MMA on cognition are not well documented. Although limited, there is evidence that the associations between vitamin B 12 status and cognitive function scores are stronger in patients with depression than in participants without depression (4, 28, 37) . Decreased performance on visual memory and verbal fluency tests has been reported in depressed people with low vitamin B 12 levels (37) . Although data on depression and MMA are limited, in the American Women's Health and Ageing Study, depressed participants, especially those with severe depression, had significantly higher MMA than the mentally well participants (34) .
As described in another report from the Hordaland Homocysteine Study, elevated plasma tHcy was associated with low A. VOGIATZOGLOU et al.
episodic memory performance (63) . Although high plasma tHcy was associated with lower performance in episodic memory in the current study, there was no evidence of effect modification on this association by low levels of vitamin B 12 . This is probably attributable to the low number of participants with high plasma tHcy and low vitamin B 12 . It has also been reported that the association of tHcy with cognition is modified by the presence of the ApoE ?4 allele (64). However, in our present study, no interaction was observed between plasma tHcy and ApoE status.
This study overcame several limitations of previous studies, such as the use of a single marker of vitamin B 12 status, so that more subtle associations were detected. Furthermore, the use of various cognitive tests assessing different domains of cognitive function is an advantage. Other strengths include the size of the cohort and its population-based setting. However, several limitations should be taken into considerations. The study's cross-sectional design does not allow interpretation of causality and cannot demonstrate whether the observed association with vitamin B 12 status precedes or results from the cognitive impairment or depression. Moreover, multiple significance testing was conducted, and it is possible that spurious significant associations could be observed.
Another possible drawback is that the impaired cognition or depression itself may have caused the low vitamin B 12 status by an alteration of the diet and its quality through decreased food intake. This is unlikely in this sample because participants were not seriously impaired. However, it cannot be ruled out that cognitive impairment causes both depressive symptoms and low vitamin B 12 status via unrecognized pathophysiological mechanisms or behavioral modifications affecting dietary intake of vitamin B 12 . Finally, not all participants completed the entire neuropsychological test battery owing to participant compliance. Results for tests with relatively small sample sizes could be affected by selection bias and should be interpreted cautiously.
The presence of additional factors (ApoE ?4 allele and depression) that contribute to cognitive impairment strengthened the associations between low vitamin B 12 status and cognition. Although the biological mechanisms by which ApoE ?4 or depression modulates the effects of low vitamin B 12 on cognitive function are unknown, we hypothesize that patients with the ApoE ?4 allele or patients exhibiting depressive symptoms may be those most likely to benefit from vitamin B 12 supplementation in an elderly population. Long-term trials in participants with low vitamin B 12 status are required to assess the relevance of vitamin B 12 supplementation to the prevention of cognitive decline in older people, and we suggest that such trials be stratified into those with and without the ApoE ?4 allele or into those with and without depression.
